Frontlight ResearchEarly access
Trial site
Sakarya
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria3 trials
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 34 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026